Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, Quest Diagnostics Inc reported revenue of $11.04B, up 11.8% year over year. Operating margin was 14.1% and net margin 9.0%, on a free-cash-flow margin of 12.3% with capital expenditure at 4.8% of revenue. Every figure is computed directly from DGX's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $11.04B | 14.1% | 9.0% |
| FY2024 | $9.87B | 13.6% | 8.8% |
| FY2023 | $9.25B | 13.6% | 9.2% |
| FY2022 | $9.88B | 14.4% | 9.6% |
| FY2021 | $10.79B | 22.1% | 18.5% |
How does DGX compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: AACG · ABSI · ACCS · ACHC · ACM · ADUS
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.